Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Could impaired mTORC1 nutrient sensing contribute to obesity-induced thyroid dysfunction?
Camila L. Rossetti, Bruna L. Alves, Ernesto Bernal-Mizrachi, Joao Pedro Werneck-de-Castro
Camila L. Rossetti, Bruna L. Alves, Ernesto Bernal-Mizrachi, Joao Pedro Werneck-de-Castro
View: Text | PDF
Letter to the Editor Endocrinology Metabolism

Could impaired mTORC1 nutrient sensing contribute to obesity-induced thyroid dysfunction?

  • Text
  • PDF
Abstract

Authors

Camila L. Rossetti, Bruna L. Alves, Ernesto Bernal-Mizrachi, Joao Pedro Werneck-de-Castro

×

Figure 1

HFD reduces thyroidal mTORC1 activity and circulating T4 without thyroid enlargement.

Options: View larger image (or click on image) Download as PowerPoint
HFD reduces thyroidal mTORC1 activity and circulating T4 without thyroid...
(A) Initial working hypothesis: obesogenic diets increase nutrient, hormone, and growth factor availability, thereby activating mTORC1 and promoting TD with gland enlargement. (B–D) mTORC1 activity, assessed by phospho-S6/total S6 (pS6/tS6), in thyroid protein extracts from male C57BL/6 mice fed regular diet (RD) or HFD after 3 or 12 weeks (B), 18 weeks (C), and 20 weeks (D), with representative immunoblots. (E–J) Thyroid weight (E), thyroid weight/body weight ratio (F), thyroxine (T4) (G), thyrotropin (TSH) (H), thyroidal gene expression (I), and thyroid NIS protein (J) levels in the cohort shown in B. (K) Plasma T4 levels in an independent cohort fed RD or HFD for 8 or 12 weeks. Data are shown as mean ± SEM; dots indicate individual mice. P values are shown in the graphs and were considered significant at P ≤ 0.05. One-way ANOVA followed by Dunnett’s correction and/or linear trend was used in B and E–J. Two-tailed Student’s t test was used in C, D, and K. Plasma total T4 (CSB-E05083m) and TSH (CSB-E05116m) were measured by ELISA (Cusabio). NIS antibody: MilliporeSigma (ABC1453).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts